Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Peking, China Clinical Trials

A listing of Peking, China clinical trials actively recruiting patients volunteers.

RESULTS

Found (5) clinical trials

PD-L1 Expression in Advanced Osteosarcoma

The expression level of PD-L1 on tumor cells is a pivotal point which might have some influence on prognosis, especially for those who might use PD-1 or PD-L1 antibody for treatment. The aim of this study is to detect the expression of PD-1 on advaced osteosarcoma patient who might use ...

Phase N/A

0.0 miles

Learn More »

AcoArt IV / SFA in China:Drug-eluting Balloon for SFA Angioplasty Evaluation in China

The registry is a prospective, multicenter, single arm post-market real-world registry in China assessing the clinical use, safety and outcomes of the Orchid 035 DCB Catheter in the Superficial Femoral Artery (SFA) and Popliteal Arteries (PA).

Phase N/A

0.0 miles

Learn More »

Accelerated Partial Breast Irradiation With IMRT in Early Breast Cancer

This study is a national multicenter phase II prospective clinical trial to enroll low-risk breast cancer treat with breast-conserving surgery. All eligible patients will receive ABPI to a total dose of 40Gy, in 10 fractions, 4Gy/fx/day, within 2 weeks. Intensity modulated radiation therapy (IMRT) technique is used. During Follow up, ...

Phase

3.37 miles

Learn More »

Randomized Trial of Accelerated Partial Breast Irradiation

This study is a single-center phase II randomized clinical trial to enroll low-risk breast cancer treat with breast-conserving surgery. All eligible patients are randomized to receive either ABPI (40Gy/10fx/2wks) or WBI(43.5Gy/15fx/3wks). Intensity modulated radiation therapy (IMRT) technique is used. Grade 2 or more acute and late toxicities are prospectively evaluated ...

Phase

3.37 miles

Learn More »

Effect of Intravenous Metoprolol Combining RIPC on Myocardial Protection in STEMI Patients

This study is a multicenter randomized controlled clinical trial, and planning to enroll 1200 patients with anterior STEMI. At the first medical contactpatients who meet the inclusion/exclusion criteria are divided into different groups before reperfusion. Patients randomize into placbo, Metoprolol, RIPC and Metorolol+RIPC groups. Subsequently, the investigator conduct diagnosis and ...

Phase

4.83 miles

Learn More »